Pramiracetam Powder

Regular price
475.00 AED
Unit price
per


Size 10 g

Pay in 4 interest-free installments of $133.12 with

Pramiracetam Powder
10 g
Regular price
475.00 AED
Unit price
per

Pramiracetam Powder

Size 10 g

Fast answers, clear expectations, and safety notes:

1
  • Supports memory & cognition
  • Drives sharper focus & motivation
  • Powder format for flexible, stack-ready dosing
2

Pramiracetam is a next-generation racetam nootropic, often chosen by experienced users seeking stronger effects than Piracetam. Known for its intensity, it’s valued for enhancing focus, learning capacity, and drive—making it a favorite for long study sessions or deep work. Our pure powder gives you precision and better value per gram.

3
4

Pramiracetam is believed to modulate acetylcholine pathways and boost high-affinity choline uptake, supporting memory and learning. It also influences glutamate and other neurotransmitter systems, improving synaptic efficiency. This makes it a potent tool for cognitive performance, especially when stacked smartly.

5
  • Dose: 300–600 mg, 1–2 times daily
  • Form: Powder for cost-effective, flexible dosing
  • Tip: Always stack with a choline donor (Alpha-GPC or CDP-Choline) to maximize results and reduce racetam headaches
6
  • Flexible dosing for advanced users
  • Best value per gram
  • Easy to integrate into custom stacks
7

General safety: Not for children. Avoid use if pregnant or nursing. If you have a medical condition or take medication, consult your healthcare professional before use. Do not exceed the recommended serving. Store in a cool, dry place.

EVIDENCE SNAPSHOT

Pramiracetam — Evidence Snapshot

Hover or tap the numbered chips to see the study details.
  • Trauma Memory

    In men with brain injury, pramiracetam 1,200 mg/day improved certain memory measures compared with placebo in a double-blind study. [PubMed ↗] [PubMed ↗]

  • Strong Racetam

    Animal work supports pramiracetam’s role in enhancing spatial learning and retention via cholinergic modulation. [PubMed ↗] [PubMed ↗]

  • Mixed Dementia

    Subsequent clinical research in Alzheimer’s disease has been mixed, so pramiracetam remains an experimental nootropic rather than an approved therapy. [PubMed ↗] [PubMed ↗]

You may also like

No products found